pSivida raises $3.7m, re-appoints Aston to board

Perth-based biotechnology company pSivida Ltd will raise $3.7 million through a placement to Australian and European investors, to fund development of its macular edema treatment.

 

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

(first time users)
FREE: 8 articles per month + twice daily business email alerts
Category: 

Comments:

Exporters

LabelValue
Rio Tinto$21.40bn
BHP Billiton Iron Ore$17.97bn
North West Shelf Venture$16.84bn
Fortescue Metals Group$8.12bn
Gold Corporation$5.81bn
Others$52.43bn
FMG
CF 2011
CF Q3 FY12
Elizabeth Quay
IBM Tech Staff
Subiaco Revenue
R&D Expenditure
Online Revenue
Female Uni Chancellors
Executive Salary 2012
Employment growth
Population growth
WA employment figure
WA GST return
Business Credit growth
Green Star Certified
SMEs Social Media use
Perth's Median hose price
China investment in WA
China GDP growth
Education Revolution allocation
Indigenous resource workers

Feedback Form